Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""SUBSTANCE abuse"" wg kryterium: Temat


Starter badań:

Tytuł :
Evaluation of an Unsanctioned Safe Consumption Site in the United States.
Autorzy :
Kral AH; RTI International, Berkeley, CA .
Lambdin BH; RTI International, Berkeley, CA .
Wenger LD; RTI International, Berkeley, CA .
Davidson PJ; University of California, San Diego, San Diego, CA.
Pokaż więcej
Źródło :
The New England journal of medicine [N Engl J Med] 2020 Aug 06; Vol. 383 (6), pp. 589-590. Date of Electronic Publication: 2020 Jul 08.
Typ publikacji :
Letter
MeSH Terms :
Harm Reduction*
Needle-Exchange Programs*
Substance Abuse, Intravenous*
Drug Overdose/*epidemiology
Opioid Epidemic/*mortality
Analgesics, Opioid ; Drug Overdose/drug therapy ; Drug Overdose/mortality ; Humans ; Naloxone/therapeutic use ; Narcotic Antagonists/therapeutic use ; Opioid-Related Disorders/complications ; Public Health Practice ; Substance Abuse Treatment Centers ; United States/epidemiology
Opinia redakcyjna
Tytuł :
Reduction in the population prevalence of hepatitis C virus viraemia among people who inject drugs associated with scale-up of direct-acting anti-viral therapy in community drug services: real-world data.
Autorzy :
Palmateer NE; Glasgow Caledonian University, Cowcaddens Road, Glasgow, G4 0BA, UK.; Public Health Scotland, Glasgow, UK.
McAuley A; Glasgow Caledonian University, Cowcaddens Road, Glasgow, G4 0BA, UK.; Public Health Scotland, Glasgow, UK.
Dillon JF; University of Dundee, Dundee, UK.
McDonald S; Glasgow Caledonian University, Cowcaddens Road, Glasgow, G4 0BA, UK.
Yeung A; Glasgow Caledonian University, Cowcaddens Road, Glasgow, G4 0BA, UK.; Public Health Scotland, Glasgow, UK.
Smith S; Glasgow Caledonian University, Cowcaddens Road, Glasgow, G4 0BA, UK.; Public Health Scotland, Glasgow, UK.
Barclay S; Glasgow Caledonian University, Cowcaddens Road, Glasgow, G4 0BA, UK.; Glasgow Royal Infirmary, Glasgow, UK.
Hayes P; Royal Infirmary of Edinburgh, Edinburgh, UK.
Shepherd SJ; West of Scotland Specialist Virology Centre, Glasgow, UK.
Gunson RN; West of Scotland Specialist Virology Centre, Glasgow, UK.
Goldberg DJ; Glasgow Caledonian University, Cowcaddens Road, Glasgow, G4 0BA, UK.; Public Health Scotland, Glasgow, UK.
Hickman M; University of Bristol, Bristol, UK.
Hutchinson SJ; Glasgow Caledonian University, Cowcaddens Road, Glasgow, G4 0BA, UK.; Public Health Scotland, Glasgow, UK.
Pokaż więcej
Źródło :
Addiction (Abingdon, England) [Addiction] 2021 Oct; Vol. 116 (10), pp. 2893-2907. Date of Electronic Publication: 2021 May 05.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Hepatitis C*/drug therapy
Hepatitis C*/epidemiology
Hepatitis C, Chronic*/drug therapy
Pharmaceutical Preparations*
Substance Abuse, Intravenous*/drug therapy
Substance Abuse, Intravenous*/epidemiology
Antiviral Agents/therapeutic use ; Hepacivirus ; Humans ; Prevalence ; Viremia/drug therapy ; Viremia/epidemiology
Czasopismo naukowe
Tytuł :
The impact of direct-acting antivirals on hepatitis C viraemia among people who inject drugs in England; real-world data 2011-2018.
Autorzy :
Bardsley M; National Infection Service, Public Health England, London, UK.
Heinsbroek E; National Infection Service, Public Health England, London, UK.
Harris R; National Infection Service, Public Health England, London, UK.
Croxford S; National Infection Service, Public Health England, London, UK.
Edmundson C; National Infection Service, Public Health England, London, UK.
Hope V; National Infection Service, Public Health England, London, UK.; Public Health Institute, Liverpool John Moores University, Liverpool, UK.
Hassan N; National Infection Service, Public Health England, London, UK.
Ijaz S; National Infection Service, Public Health England, London, UK.
Mandal S; National Infection Service, Public Health England, London, UK.
Shute J; National Infection Service, Public Health England, London, UK.
Hutchinson SJ; Glasgow Caledonian University, Glasgow, UK.; Public Health Scotland, Glasgow, UK.
Hickman M; Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK.
Sinka K; National Infection Service, Public Health England, London, UK.
Phipps E; National Infection Service, Public Health England, London, UK.
Pokaż więcej
Źródło :
Journal of viral hepatitis [J Viral Hepat] 2021 Oct; Vol. 28 (10), pp. 1452-1463. Date of Electronic Publication: 2021 Jul 29.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Hepatitis C*/drug therapy
Hepatitis C*/epidemiology
Hepatitis C, Chronic*/drug therapy
Pharmaceutical Preparations*
Substance Abuse, Intravenous*/complications
Substance Abuse, Intravenous*/drug therapy
Substance Abuse, Intravenous*/epidemiology
Antiviral Agents/therapeutic use ; Humans ; Male ; Prevalence ; Viremia/drug therapy ; Viremia/epidemiology
Czasopismo naukowe
Tytuł :
Endocarditis and the impact of intravenous drug use: a cohort study.
Autorzy :
Lawrence CHD; Centre for Clinical Infection, James Cook University Hospital, Middlesbrough, UK.
Cheaveau J; Centre for Clinical Infection, James Cook University Hospital, Middlesbrough, UK.
Kavourides M; Faculty of Medical Sciences, Newcastle University Medical School, Newcastle upon Tyne, UK.
Chadwick D; Centre for Clinical Infection, James Cook University Hospital, Middlesbrough, UK.
McCarron B; Centre for Clinical Infection, James Cook University Hospital, Middlesbrough, UK.
Pokaż więcej
Źródło :
Infectious diseases (London, England) [Infect Dis (Lond)] 2021 Oct; Vol. 53 (10), pp. 772-778. Date of Electronic Publication: 2021 Jun 08.
Typ publikacji :
Journal Article
MeSH Terms :
Endocarditis*/epidemiology
Endocarditis, Bacterial*/epidemiology
Pharmaceutical Preparations*
Substance Abuse, Intravenous*/complications
Substance Abuse, Intravenous*/epidemiology
Cohort Studies ; Humans ; Retrospective Studies
Czasopismo naukowe
Tytuł :
Hepatitis C Care Cascades for 3 Populations at High Risk: Low-income Trans Women, Young People Who Inject Drugs, and Men Who Have Sex With Men and Inject Drugs.
Autorzy :
Facente SN; School of Public Health, Division of Epidemiology and Biostatistics, University of California Berkeley, Berkeley, California, USA.; Facente Consulting, Richmond, California, USA.
Patel S; Department of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, California, USA.
Hecht J; San Francisco AIDS Foundation, San Francisco, California, USA.
Wilson E; San Francisco Department of Public Health, San Francisco, California, USA.
McFarland W; Department of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, California, USA.; San Francisco Department of Public Health, San Francisco, California, USA.
Page K; University of New Mexico, Albuquerque, New Mexico, USA.
Vickerman P; Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK.
Fraser H; Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK.
Burk K; San Francisco Department of Public Health, San Francisco, California, USA.
Morris MD; Department of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, California, USA.
Pokaż więcej
Źródło :
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America [Clin Infect Dis] 2021 Sep 15; Vol. 73 (6), pp. e1290-e1295.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural
MeSH Terms :
HIV Infections*
Hepatitis C*/drug therapy
Hepatitis C*/epidemiology
Pharmaceutical Preparations*
Sexual and Gender Minorities*
Substance Abuse, Intravenous*/complications
Substance Abuse, Intravenous*/epidemiology
Adolescent ; Adult ; Cross-Sectional Studies ; Female ; Hepacivirus ; Homosexuality, Male ; Humans ; Male
Czasopismo naukowe
Tytuł :
HIV-positive persons who inject drugs experience poor health outcomes and unmet needs for care services.
Autorzy :
Dasgupta S; Division of HIV/AIDS Prevention, Centers for Disease Control and Prevention, Atlanta, GA, USA.
Tie Y; Division of HIV/AIDS Prevention, Centers for Disease Control and Prevention, Atlanta, GA, USA.
Lemons-Lyn A; Division of HIV/AIDS Prevention, Centers for Disease Control and Prevention, Atlanta, GA, USA.
Broz D; Division of HIV/AIDS Prevention, Centers for Disease Control and Prevention, Atlanta, GA, USA.
Buchacz K; Division of HIV/AIDS Prevention, Centers for Disease Control and Prevention, Atlanta, GA, USA.
Shouse RL; Division of HIV/AIDS Prevention, Centers for Disease Control and Prevention, Atlanta, GA, USA.
Pokaż więcej
Źródło :
AIDS care [AIDS Care] 2021 Sep; Vol. 33 (9), pp. 1146-1154. Date of Electronic Publication: 2020 Sep 27.
Typ publikacji :
Journal Article; Research Support, U.S. Gov't, P.H.S.
MeSH Terms :
Drug Users*
HIV Infections*/complications
HIV Infections*/epidemiology
Pharmaceutical Preparations*
Substance Abuse, Intravenous*/complications
Substance Abuse, Intravenous*/epidemiology
Adult ; Humans ; Outcome Assessment, Health Care
Czasopismo naukowe
Tytuł :
Assessment of PrEP Awareness, PrEP Discussion with a Provider, and PrEP Use by Transmission Risk Group with an Emphasis on the Southern United States.
Autorzy :
Jones JT; Division of HIV/AIDS Prevention, National Center for HIV, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, 1600 Clifton Rd, Atlanta, GA, 30333, USA. .
Smith DK; Division of HIV/AIDS Prevention, National Center for HIV, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, 1600 Clifton Rd, Atlanta, GA, 30333, USA.
Wiener J; Division of HIV/AIDS Prevention, National Center for HIV, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, 1600 Clifton Rd, Atlanta, GA, 30333, USA.
August EM; Division of HIV/AIDS Prevention, National Center for HIV, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, 1600 Clifton Rd, Atlanta, GA, 30333, USA.
Finlayson T; Division of HIV/AIDS Prevention, National Center for HIV, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, 1600 Clifton Rd, Atlanta, GA, 30333, USA.
Wejnert C; Division of HIV/AIDS Prevention, National Center for HIV, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, 1600 Clifton Rd, Atlanta, GA, 30333, USA.
Pokaż więcej
Corporate Authors :
National HIV Behavioral Surveillance Study Group
Źródło :
AIDS and behavior [AIDS Behav] 2021 Sep; Vol. 25 (9), pp. 2985-2991. Date of Electronic Publication: 2021 Feb 01.
Typ publikacji :
Journal Article
MeSH Terms :
Anti-HIV Agents*/therapeutic use
Drug Users*
HIV Infections*/drug therapy
HIV Infections*/epidemiology
HIV Infections*/prevention & control
Pre-Exposure Prophylaxis*
Sexual and Gender Minorities*
Substance Abuse, Intravenous*/drug therapy
Substance Abuse, Intravenous*/epidemiology
Health Knowledge, Attitudes, Practice ; Homosexuality, Male ; Humans ; Male ; United States/epidemiology
Czasopismo naukowe
Tytuł :
The naloxone delivery cascade: Identifying disparities in access to naloxone among people who inject drugs in Los Angeles and San Francisco, CA.
Autorzy :
Kinnard EN; Division of Epidemiology, University of California Berkeley School of Public Health, 2121 Berkeley Way, Berkeley, CA, 94720, USA; Community Health Research Division, RTI International, 2150 Shattuck Avenue, Suite 800, Berkeley, CA, 94704, USA. Electronic address: .
Bluthenthal RN; Department of Preventive Medicine, Institute for Prevention Research, Keck School of Medicine, University of Southern California, 2001 N. Soto St., Los Angeles, CA, 90033, USA.
Kral AH; Community Health Research Division, RTI International, 2150 Shattuck Avenue, Suite 800, Berkeley, CA, 94704, USA.
Wenger LD; Community Health Research Division, RTI International, 2150 Shattuck Avenue, Suite 800, Berkeley, CA, 94704, USA.
Lambdin BH; Community Health Research Division, RTI International, 2150 Shattuck Avenue, Suite 800, Berkeley, CA, 94704, USA; Department of Epidemiology and Biostatistics, University of California San Francisco, 550 16th Street, Second Floor, San Francisco, CA, 94158, USA; Department of Global Health, University of Washington, 3980 15th Ave NE, Seattle, WA, 98195, USA.
Pokaż więcej
Źródło :
Drug and alcohol dependence [Drug Alcohol Depend] 2021 Aug 01; Vol. 225, pp. 108759. Date of Electronic Publication: 2021 May 21.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural
MeSH Terms :
Drug Overdose*/epidemiology
Opioid-Related Disorders*
Pharmaceutical Preparations*
Substance Abuse, Intravenous*/drug therapy
Substance Abuse, Intravenous*/epidemiology
Humans ; Los Angeles/epidemiology ; Naloxone/therapeutic use ; San Francisco/epidemiology
Czasopismo naukowe
Tytuł :
Use of Tele-Mental Health in Conjunction With In-Person Care: A Qualitative Exploration of Implementation Models.
Autorzy :
Uscher-Pines L; RAND Corporation, Arlington, Virginia (Uscher-Pines) and Santa Monica, California (Qureshi); U.S. Department of Veterans Affairs Greater Los Angeles Medical Center, Los Angeles (Raja, Mehrotra); Department of Health Care Policy, Harvard Medical School, Boston (Huskamp, Busch); McLean Hospital, Belmont, Massachusetts (Busch); Beth Israel Deaconess Medical Center, Boston (Mehrotra).
Raja P; RAND Corporation, Arlington, Virginia (Uscher-Pines) and Santa Monica, California (Qureshi); U.S. Department of Veterans Affairs Greater Los Angeles Medical Center, Los Angeles (Raja, Mehrotra); Department of Health Care Policy, Harvard Medical School, Boston (Huskamp, Busch); McLean Hospital, Belmont, Massachusetts (Busch); Beth Israel Deaconess Medical Center, Boston (Mehrotra).
Qureshi N; RAND Corporation, Arlington, Virginia (Uscher-Pines) and Santa Monica, California (Qureshi); U.S. Department of Veterans Affairs Greater Los Angeles Medical Center, Los Angeles (Raja, Mehrotra); Department of Health Care Policy, Harvard Medical School, Boston (Huskamp, Busch); McLean Hospital, Belmont, Massachusetts (Busch); Beth Israel Deaconess Medical Center, Boston (Mehrotra).
Huskamp HA; RAND Corporation, Arlington, Virginia (Uscher-Pines) and Santa Monica, California (Qureshi); U.S. Department of Veterans Affairs Greater Los Angeles Medical Center, Los Angeles (Raja, Mehrotra); Department of Health Care Policy, Harvard Medical School, Boston (Huskamp, Busch); McLean Hospital, Belmont, Massachusetts (Busch); Beth Israel Deaconess Medical Center, Boston (Mehrotra).
Busch AB; RAND Corporation, Arlington, Virginia (Uscher-Pines) and Santa Monica, California (Qureshi); U.S. Department of Veterans Affairs Greater Los Angeles Medical Center, Los Angeles (Raja, Mehrotra); Department of Health Care Policy, Harvard Medical School, Boston (Huskamp, Busch); McLean Hospital, Belmont, Massachusetts (Busch); Beth Israel Deaconess Medical Center, Boston (Mehrotra).
Mehrotra A; RAND Corporation, Arlington, Virginia (Uscher-Pines) and Santa Monica, California (Qureshi); U.S. Department of Veterans Affairs Greater Los Angeles Medical Center, Los Angeles (Raja, Mehrotra); Department of Health Care Policy, Harvard Medical School, Boston (Huskamp, Busch); McLean Hospital, Belmont, Massachusetts (Busch); Beth Israel Deaconess Medical Center, Boston (Mehrotra).
Pokaż więcej
Źródło :
Psychiatric services (Washington, D.C.) [Psychiatr Serv] 2020 May 01; Vol. 71 (5), pp. 419-426. Date of Electronic Publication: 2020 Jan 30.
Typ publikacji :
Journal Article; Multicenter Study; Research Support, N.I.H., Extramural
MeSH Terms :
Models, Psychological*
Substance Abuse Treatment Centers*
Mental Health Services/*organization & administration
Telemedicine/*organization & administration
Attitude of Health Personnel ; Humans ; Interviews as Topic ; Qualitative Research ; United States ; United States Substance Abuse and Mental Health Services Administration
Czasopismo naukowe
Tytuł :
Correlates of injection-related wounds and skin infections amongst persons who inject drugs and use a syringe service programme: A single center study.
Autorzy :
Cahn BA; Memorial Sloan Kettering Cancer Center, New York, New York, USA.
Bartholomew TS; Department of Public Health Services, University of Miami Miller School of Medicine, Miami, Florida, USA.
Patel HP; Department of Medical Education, University of Miami Miller School of Medicine, Miami, Florida, USA.
Pastar I; Dr. Phillip Frost Department of Dermatology and Cutaneous Surgery, Wound Healing and Regenerative Medicine Research Program, University of Miami Miller School of Medicine, Miami, Florida, USA.
Tookes HE; Division of Infectious Diseases, Department of Medicine, University of Miami Miller School of Medicine, Miami, Florida, USA.
Lev-Tov H; Dr. Phillip Frost Department of Dermatology and Cutaneous Surgery, Wound Healing and Regenerative Medicine Research Program, University of Miami Miller School of Medicine, Miami, Florida, USA.
Pokaż więcej
Źródło :
International wound journal [Int Wound J] 2021 Oct; Vol. 18 (5), pp. 701-707. Date of Electronic Publication: 2021 Feb 15.
Typ publikacji :
Journal Article
MeSH Terms :
Drug Users*
HIV Infections*
Pharmaceutical Preparations*
Skin Diseases, Infectious*/epidemiology
Skin Diseases, Infectious*/etiology
Substance Abuse, Intravenous*/epidemiology
Adult ; Female ; Humans ; Syringes
Czasopismo naukowe
Tytuł :
Global cascade of care for chronic hepatitis C virus infection: A systematic review and meta-analysis.
Autorzy :
Yousafzai MT; The Kirby Institute, UNSW Sydney, Sydney, NSW, Australia.
Bajis S; The Kirby Institute, UNSW Sydney, Sydney, NSW, Australia.
Alavi M; The Kirby Institute, UNSW Sydney, Sydney, NSW, Australia.
Grebely J; The Kirby Institute, UNSW Sydney, Sydney, NSW, Australia.
Dore GJ; The Kirby Institute, UNSW Sydney, Sydney, NSW, Australia.
Hajarizadeh B; The Kirby Institute, UNSW Sydney, Sydney, NSW, Australia.
Pokaż więcej
Źródło :
Journal of viral hepatitis [J Viral Hepat] 2021 Oct; Vol. 28 (10), pp. 1340-1354. Date of Electronic Publication: 2021 Jul 31.
Typ publikacji :
Journal Article; Meta-Analysis; Research Support, Non-U.S. Gov't; Review; Systematic Review
MeSH Terms :
Hepatitis C*/drug therapy
Hepatitis C*/epidemiology
Hepatitis C, Chronic*/drug therapy
Hepatitis C, Chronic*/epidemiology
Substance Abuse, Intravenous*/drug therapy
Antiviral Agents/therapeutic use ; Hepacivirus ; Humans
Czasopismo naukowe
Tytuł :
The changing characteristics of patients infected with chronic hepatitis C virus from 2014 to 2019: Real-world data from the German Hepatitis C-Registry (DHC-R).
Autorzy :
Hüppe D; Gastroenterologische Gemeinschaftspraxis Herne, Herne, Germany.
Stoehr A; Institut für Interdisziplinäre Medizin, Hamburg, Germany.
Buggisch P; Institut für Interdisziplinäre Medizin, Hamburg, Germany.
Mauss S; Centre for HIV and Hepatogastroenterology, Duesseldorf, Germany.
Klinker H; Medizinische Klinik II, Universitätsklinikum Würzburg, Würzburg, Germany.
Teuber G; Practice PD Dr. med. G. Teuber, Frankfurt am Main, Germany.
Hidde D; AbbVie Germany GmbH & Co. KG, Wiesbaden, Germany.
Lohmann K; AbbVie Germany GmbH & Co. KG, Wiesbaden, Germany.
Bondin M; AbbVie Inc, North Chicago, Illinois, USA.
Wedemeyer H; Leberstiftungs-GmbH Deutschland, Hannover, Germany.; Klinik für Gastroenterologie, Hepatologie und Endokrinologie, Medizinische Hochschule Hannover, Hannover, Germany.; Klinik für Gastroenterologie und Hepatologie, Universitätsklinikum Essen, Universität Duisburg-Essen, Essen, Germany.
Pokaż więcej
Źródło :
Journal of viral hepatitis [J Viral Hepat] 2021 Oct; Vol. 28 (10), pp. 1474-1483. Date of Electronic Publication: 2021 Aug 12.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Hepatitis C*/drug therapy
Hepatitis C, Chronic*/drug therapy
Hepatitis C, Chronic*/epidemiology
Substance Abuse, Intravenous*/drug therapy
Antiviral Agents/therapeutic use ; Hepacivirus ; Humans ; Middle Aged ; Prospective Studies ; Registries
Czasopismo naukowe
Tytuł :
Syringe Coverage Among People Who Inject Drugs in West Virginia, USA.
Autorzy :
Allen ST; Department of Health, Behavior and Society, Johns Hopkins Bloomberg School of Public Health, 624 N. Broadway, Baltimore, MD, 21205, USA. .
White RH; Department of Health, Behavior and Society, Johns Hopkins Bloomberg School of Public Health, 624 N. Broadway, Baltimore, MD, 21205, USA.
O'Rourke A; Department of Psychological and Brain Sciences, DC Center for AIDS Research, George Washington University, 2125 G St. NW, Washington, DC, 20052, USA.
Schneider KE; Department of Mental Health, Johns Hopkins Bloomberg School of Public Health, 624 N. Broadway, Baltimore, MD, 21205, USA.
Weir BW; Department of Health, Behavior and Society, Johns Hopkins Bloomberg School of Public Health, 624 N. Broadway, Baltimore, MD, 21205, USA.
Lucas GM; Department of Medicine, Johns Hopkins School of Medicine, 1830 E. Monument St., Baltimore, MD, 21205, USA.
Kilkenny ME; Cabell-Huntington Health Department, 703 7th Ave., Huntington, WV, 25701, USA.
Sherman SG; Department of Health, Behavior and Society, Johns Hopkins Bloomberg School of Public Health, 624 N. Broadway, Baltimore, MD, 21205, USA.
Pokaż więcej
Źródło :
AIDS and behavior [AIDS Behav] 2021 Oct; Vol. 25 (10), pp. 3377-3385. Date of Electronic Publication: 2021 Apr 22.
Typ publikacji :
Journal Article
MeSH Terms :
HIV Infections*/epidemiology
HIV Infections*/prevention & control
Pharmaceutical Preparations*
Substance Abuse, Intravenous*/epidemiology
Humans ; Needle-Exchange Programs ; Syringes ; West Virginia/epidemiology
Czasopismo naukowe
Tytuł :
Increased utilization of buprenorphine and methadone in 2018 compared to 2015 among Seattle-area persons who inject drugs.
Autorzy :
Poorman E; University of Washington, Division of General Internal Medicine, Department of Medicine, 325 9th Avenue, Seattle, WA 98104, USA.
Glick SN; Public Health-Seattle & King County, HIV/STD Program, 401 Fifth Ave, Suite 1250, Seattle, WA 98104, USA; University of Washington, Division of Allergy and Infectious Diseases, Department of Medicine, 325 9th Avenue, Box 359777, Seattle, WA 98104, USA. Electronic address: .
Hiser JKD; University of Washington, Division of General Internal Medicine, Department of Medicine, 325 9th Avenue, Seattle, WA 98104, USA.
Bhatraju E; University of Washington, Division of General Internal Medicine, Department of Medicine, 325 9th Avenue, Seattle, WA 98104, USA.
Tsui JI; University of Washington, Division of General Internal Medicine, Department of Medicine, 325 9th Avenue, Seattle, WA 98104, USA.
Pokaż więcej
Źródło :
Journal of substance abuse treatment [J Subst Abuse Treat] 2021 Oct; Vol. 129, pp. 108375. Date of Electronic Publication: 2021 Mar 19.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
MeSH Terms :
Buprenorphine*
Drug Users*
Opioid-Related Disorders*/drug therapy
Pharmaceutical Preparations*
Substance Abuse, Intravenous*/epidemiology
Humans ; Methadone/therapeutic use ; Opiate Substitution Treatment
Czasopismo naukowe
Tytuł :
Impact of cumulative incarceration and the post-release period on syringe-sharing among people who inject drugs in Tijuana, Mexico: a longitudinal analysis.
Autorzy :
Rivera Saldana CD; Division of Infectious Diseases and Global Public Health, Department of Medicine, University of California San Diego, La Jolla, CA, USA.; School of Public Health, San Diego State University, San Diego, CA, USA.
Beletsky L; Division of Infectious Diseases and Global Public Health, Department of Medicine, University of California San Diego, La Jolla, CA, USA.; School of Law and Bouve College of Health Sciences, Northeastern University, Boston, MA, USA.
Borquez A; Division of Infectious Diseases and Global Public Health, Department of Medicine, University of California San Diego, La Jolla, CA, USA.
Kiene SM; School of Public Health, San Diego State University, San Diego, CA, USA.
Strathdee SA; Division of Infectious Diseases and Global Public Health, Department of Medicine, University of California San Diego, La Jolla, CA, USA.
Zúñiga ML; School of Social Work, San Diego State University, San Diego, CA, USA.
Martin NK; Division of Infectious Diseases and Global Public Health, Department of Medicine, University of California San Diego, La Jolla, CA, USA.; Population Health Sciences, University of Bristol, Bristol, UK.
Cepeda J; Division of Infectious Diseases and Global Public Health, Department of Medicine, University of California San Diego, La Jolla, CA, USA.
Pokaż więcej
Źródło :
Addiction (Abingdon, England) [Addiction] 2021 Oct; Vol. 116 (10), pp. 2724-2733. Date of Electronic Publication: 2021 Mar 03.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.
MeSH Terms :
HIV Infections*
Pharmaceutical Preparations*
Substance Abuse, Intravenous*/epidemiology
Cohort Studies ; Female ; Humans ; Infant, Newborn ; Male ; Mexico/epidemiology ; Needle Sharing ; Syringes
Czasopismo naukowe
Tytuł :
Cost-effectiveness of hepatitis C virus (HCV) elimination strategies among people who inject drugs (PWID) in Tijuana, Mexico.
Autorzy :
Marquez LK; University of California San Diego, La Jolla, CA, USA.; San Diego State University, San Diego, CA, USA.
Fleiz C; National Institute of Psychiatry Ramon de la Fuente Muniz, Colonia, Huipulco, Tlalpan, Ciudad de Mexico, Mexico.
Burgos JL; University of California San Diego, La Jolla, CA, USA.
Cepeda JA; University of California San Diego, La Jolla, CA, USA.
McIntosh C; University of California San Diego, La Jolla, CA, USA.
Garfein RS; University of California San Diego, La Jolla, CA, USA.
Kiene SM; San Diego State University, San Diego, CA, USA.
Brodine S; San Diego State University, San Diego, CA, USA.
Strathdee SA; University of California San Diego, La Jolla, CA, USA.
Martin NK; University of California San Diego, La Jolla, CA, USA.; University of Bristol, Bristol, UK.
Pokaż więcej
Źródło :
Addiction (Abingdon, England) [Addiction] 2021 Oct; Vol. 116 (10), pp. 2734-2745. Date of Electronic Publication: 2021 Mar 22.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms :
Hepatitis C*/drug therapy
Hepatitis C*/epidemiology
Hepatitis C*/prevention & control
Pharmaceutical Preparations*
Substance Abuse, Intravenous*/drug therapy
Antiviral Agents/therapeutic use ; Cost-Benefit Analysis ; Hepacivirus ; Humans ; Mexico/epidemiology ; Seroepidemiologic Studies
Czasopismo naukowe
Tytuł :
Racial differences in overdose training, naloxone possession, and naloxone administration among clients and nonclients of a syringe services program.
Autorzy :
Jones AA; Department of Human Development and Family Studies, The Pennsylvania State University, 105 Health and Human Development Building, University Park, PA 16802, USA. Electronic address: .
Park JN; Department of Health, Behavior, and Society, Bloomberg School of Public Health, John Hopkins University, 624 N. Broadway, Baltimore, MD 21205, USA.
Allen ST; Department of Health, Behavior, and Society, Bloomberg School of Public Health, John Hopkins University, 624 N. Broadway, Baltimore, MD 21205, USA.
Schneider KE; Department of Health, Behavior, and Society, Bloomberg School of Public Health, John Hopkins University, 624 N. Broadway, Baltimore, MD 21205, USA.
Weir BW; Department of Health, Behavior, and Society, Bloomberg School of Public Health, John Hopkins University, 624 N. Broadway, Baltimore, MD 21205, USA.
Hunt D; Baltimore City Health Department, 100 N. Holliday St, Baltimore, MD 21202, USA.
Sherman SG; Department of Health, Behavior, and Society, Bloomberg School of Public Health, John Hopkins University, 624 N. Broadway, Baltimore, MD 21205, USA.
Pokaż więcej
Źródło :
Journal of substance abuse treatment [J Subst Abuse Treat] 2021 Oct; Vol. 129, pp. 108412. Date of Electronic Publication: 2021 Apr 15.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms :
Drug Overdose*/drug therapy
Substance Abuse, Intravenous*/drug therapy
Adolescent ; Adult ; Cross-Sectional Studies ; Humans ; Male ; Naloxone/therapeutic use ; Narcotic Antagonists/therapeutic use ; Race Factors ; Syringes ; Young Adult
Czasopismo naukowe
Tytuł :
Living at the Confluence of Stigmas: PrEP Awareness and Feasibility Among People Who Inject Drugs in Two Predominantly Rural States.
Autorzy :
Carter G; Department of Community and Health Systems, Indiana University School of Nursing, 1125 Atwater Ave, Bloomington, IN, 47401, USA. .; Rural Center for AIDS/STD Prevention, Indiana University School of Public Health-Bloomington, Bloomington, IN, USA. .; School of Nursing, Indiana University, Bloomington, IN, USA. .
Meyerson B; Southwest Institute for Research On Women, College of Social and Behavioral Science, University of Arizona, Tucson, AZ, USA.; Family and Community Medicine, College of Medicine, University of Arizona, Tucson, AZ, USA.; Institute for LGBT Studies, University of Arizona, Tucson, AZ, USA.
Rivers P; Family and Community Medicine, College of Medicine, University of Arizona, Tucson, AZ, USA.
Crosby R; Department of Health Behavior, College of Public Health, University of Kentucky, Lexington, KY, USA.
Lawrence C; Applied Health Science, Indiana University School of Public Health-Bloomington, Bloomington, IN, USA.
Cope SD; Harm Reduction Foster Care Advocate, Tucson, AZ, USA.
DeBruicker D; Indiana Recovery Alliance, Bloomington, IN, USA.
Levin S; Harm Reduction Foster Care Advocate, Tucson, AZ, USA.; Sonoran Prevention Works, Phoenix, AZ, USA.
Meeks W; Indiana Recovery Alliance, Bloomington, IN, USA.
Thomas C; Harm Reduction Foster Care Advocate, Tucson, AZ, USA.; Sonoran Prevention Works, Phoenix, AZ, USA.
Turner B; Indiana Recovery Alliance, Bloomington, IN, USA.
Abert C; Indiana Recovery Alliance, Bloomington, IN, USA.; Southwest Recovery Alliance, Phoenix, AZ, USA.
Coles H; Sonoran Prevention Works, Phoenix, AZ, USA.
Allen A; Sonoran Prevention Works, Phoenix, AZ, USA.
Gonzalez-Fagoaga E; College of Public Health, University of Arizona, Tucson, AZ, USA.
Grivois-Shah R; Southern Arizona AIDS Foundation, Tucson, AZ, USA.
Pokaż więcej
Źródło :
AIDS and behavior [AIDS Behav] 2021 Oct; Vol. 25 (10), pp. 3085-3096. Date of Electronic Publication: 2021 May 18.
Typ publikacji :
Journal Article
MeSH Terms :
Anti-HIV Agents*/therapeutic use
HIV Infections*/drug therapy
HIV Infections*/prevention & control
Pharmaceutical Preparations*
Pre-Exposure Prophylaxis*
Substance Abuse, Intravenous*/drug therapy
Feasibility Studies ; Humans
Czasopismo naukowe
Tytuł :
Infective endocarditis in intravenous drug abusers: clinical challenges emerging from a single-centre experience.
Autorzy :
Scheggi V; Division of Cardiovascular and Perioperative Medicine, Cardiothoracovascular Department, Azienda Ospedaliero-Universitaria Careggi and University of Florence, Largo Brambilla 3, 50134, Florence, Italy. .
Del Pace S; Division of General Cardiology, Cardiothoracovascular Department, Azienda Ospedaliero-Universitaria Careggi and University of Florence, Largo Brambilla 3, 50134, Florence, Italy.
Ceschia N; Division of General Cardiology, Cardiothoracovascular Department, Azienda Ospedaliero-Universitaria Careggi and University of Florence, Largo Brambilla 3, 50134, Florence, Italy.
Vanni F; Division of General Cardiology, Cardiothoracovascular Department, Azienda Ospedaliero-Universitaria Careggi and University of Florence, Largo Brambilla 3, 50134, Florence, Italy.
Merilli I; Division of Cardiovascular and Perioperative Medicine, Cardiothoracovascular Department, Azienda Ospedaliero-Universitaria Careggi and University of Florence, Largo Brambilla 3, 50134, Florence, Italy.
Sottili E; Division of General Cardiology, Cardiothoracovascular Department, Azienda Ospedaliero-Universitaria Careggi and University of Florence, Largo Brambilla 3, 50134, Florence, Italy.
Salcuni L; Division of General Cardiology, Cardiothoracovascular Department, Azienda Ospedaliero-Universitaria Careggi and University of Florence, Largo Brambilla 3, 50134, Florence, Italy.
Zoppetti N; Institute of Applied Physics 'Nello Carrara' (IFAC), National Research Council, Sesto Fiorentino, Italy.
Alterini B; Division of Cardiovascular and Perioperative Medicine, Cardiothoracovascular Department, Azienda Ospedaliero-Universitaria Careggi and University of Florence, Largo Brambilla 3, 50134, Florence, Italy.
Cerillo A; Division of Cardiac Surgery, Cardiothoracovascular Department, Azienda Ospedaliero-Universitaria Careggi and University of Florence, Largo Brambilla 3, 50134, Florence, Italy.
Marchionni N; Division of General Cardiology, Cardiothoracovascular Department, Azienda Ospedaliero-Universitaria Careggi and University of Florence, Largo Brambilla 3, 50134, Florence, Italy.; Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy.
Stefàno PL; Division of Cardiac Surgery, Cardiothoracovascular Department, Azienda Ospedaliero-Universitaria Careggi and University of Florence, Largo Brambilla 3, 50134, Florence, Italy.; Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy.
Pokaż więcej
Źródło :
BMC infectious diseases [BMC Infect Dis] 2021 Sep 27; Vol. 21 (1), pp. 1010. Date of Electronic Publication: 2021 Sep 27.
Typ publikacji :
Journal Article
MeSH Terms :
Drug Users*
Endocarditis*/drug therapy
Endocarditis*/epidemiology
Endocarditis, Bacterial*
Substance Abuse, Intravenous*/complications
Humans ; Neoplasm Recurrence, Local ; Retrospective Studies ; Risk Factors
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies